Maple Grove, MN · Founded 2007 · Privately Held (backing)
Developer of an artificial chordae delivery system designed to resolve and restore normal mitral valve function. NeoChord is based in Maple Grove, MN and was founded in 2007. Its last reported valuation was $50 million in Jun 2015. It has raised $95.4 million across 13 recorded rounds; the latest was a $493,240 seed round in Feb 2025.
Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$95.4M
Last round
Seed Round
Feb 2025
No prints on record
No secondary trades in NeoChord shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeoChord with a free account
·The complete investor list: 18 names
·Watch NeoChord: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of NeoChord stock.
NeoChord Stock Price — Secondary Market Trades | Premier Alternatives
